Overall rank by patents
#36,856
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Ostial Corporation
USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
7
Total patents granted
2
CPC technology areas
21.6
Avg claims per patent
+33%
5-year filing velocity
The verdict
Ostial holds 7 US patents across 2 technology areas, rank #36,856 of 50,000 tracked assignees.
- #36,856
- of 50,000 US assignees by volume
- Top 50%
- by Innovation Score (35.1/100)
- 21.6
- avg claims per patent
- +33%
- filing velocity, last 5 yrs
Portfolio overview
Ostial Corporation has been granted 7 US utility patents between 2015 and 2024, placing Ostial Corporation at rank #36,856 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.6 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Ostial Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Ostial sits between Orthomerica Products, Inc. (7 patents, rank #36,852) and Outokumpu Nirosta Gmbh (7 patents, rank #36,860) - the closest US assignees by grant volume. The composite Innovation Score of 35.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 3 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ostial Corporation's 21.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ostial Corporation against peers pursuing similar technology classes.
Who files at Ostial's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Orthomerica Produ…
Orthomerica Products, Inc.
7 patents
- Orthopeutics
Orthopeutics, L.P.
7 patents
- Ortoma AB
Ortoma AB
7 patents
- Osmundson Mfg
Osmundson Mfg. Co.
7 patents
- Otto Torpedo
Otto Torpedo Company
7 patents
- Ouro Negro Tecnol…
Ouro Negro Tecnologias Em Equipamentos Industriais S/A
7 patents
- Outdoor Recreatio…
Outdoor Recreation Company of America, LLC
7 patents
- Outokumpu Nirosta
Outokumpu Nirosta GmbH
7 patents
- Ostial ◀
Ostial Corporation
7 patents
What this shows Ostial holds 7 patents at rank #36,856, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ostial
By rank, the assignees closest to #36,856 in granted patent volume.
- Orthomerica Products, Inc. #36,852 · 7 patents
- Orthopeutics, L.p. #36,853 · 7 patents
- Ortoma AB #36,854 · 7 patents
- Osmundson Mfg. Co. #36,855 · 7 patents
- Otto Torpedo Company #36,857 · 7 patents
- Ouro Negro Tecnologias Em Equipamentos Industriais S/a #36,858 · 7 patents
- Outdoor Recreation Company Of America, Llc #36,859 · 7 patents
- Outokumpu Nirosta Gmbh #36,860 · 7 patents
Leaders in A61M (Devices FOR Introducing Media INTO)
Other assignees with the most granted patents in Ostial's primary technology class.
- Becton, Dickinson And Company 1,249 in class
- Sanofi-aventis Deutschland Gmbh 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.v. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien Lp 726 in class
- Terumo Kabushiki Kaisha 724 in class
- Resmed Pty Ltd 682 in class
Ostial's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2018 | 1 | 14.3% |
| 2019 | 1 | 14.3% |
| 2021 | 1 | 14.3% |
| 2022 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
Which technologies does Ostial Corporation patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Growing
Frequently Asked Questions
How many patents does Ostial Corporation hold?
Ostial Corporation holds 7 US granted patents filed between 2015 and 2024, spanning 2 technology areas.
What is Ostial Corporation's Innovation Score?
Ostial Corporation has an Innovation Score of 35.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Ostial Corporation focus on?
Ostial Corporation's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 7 patents. The company has filed patents in 2 CPC subclasses total.
Is Ostial Corporation's patent filing rate increasing or decreasing?
Ostial Corporation's recent filing velocity is +33% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Ostial Corporation's patents?
Ostial Corporation's patents average 21.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Ostial Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Ostial's 7 grants land it in the top 50% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Ostial ranks #36,856 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.